316 related articles for article (PubMed ID: 22748658)
1. Clinical trials with immunotherapy for high-grade glioma.
Ruzevick J; Jackson C; Phallen J; Lim M
Neurosurg Clin N Am; 2012 Jul; 23(3):459-70. PubMed ID: 22748658
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for glioma: promises and challenges.
Han SJ; Zygourakis C; Lim M; Parsa AT
Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649
[TBL] [Abstract][Full Text] [Related]
3. Overview of cellular immunotherapy for patients with glioblastoma.
Vauleon E; Avril T; Collet B; Mosser J; Quillien V
Clin Dev Immunol; 2010; 2010():. PubMed ID: 20953324
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of immunomodulation in human glioblastoma.
Avril T; Vauleon E; Tanguy-Royer S; Mosser J; Quillien V
Immunotherapy; 2011 Apr; 3(4 Suppl):42-4. PubMed ID: 21524170
[TBL] [Abstract][Full Text] [Related]
5. [Cellular immunotherapy for malignant glioma].
Okamoto Y; Yamashita J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
[No Abstract] [Full Text] [Related]
6. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
Yu JS; Wheeler CJ; Zeltzer PM; Ying H; Finger DN; Lee PK; Yong WH; Incardona F; Thompson RC; Riedinger MS; Zhang W; Prins RM; Black KL
Cancer Res; 2001 Feb; 61(3):842-7. PubMed ID: 11221866
[TBL] [Abstract][Full Text] [Related]
8. Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme.
Bregy A; Wong TM; Shah AH; Goldberg JM; Komotar RJ
Cancer Treat Rev; 2013 Dec; 39(8):891-907. PubMed ID: 23790634
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy for malignant glioblastoma].
Nose T; Nakagawa K
No Shinkei Geka; 1995 Mar; 23(3):195-206. PubMed ID: 7700486
[No Abstract] [Full Text] [Related]
10. Immunotherapy in human glioblastoma.
Szabo AT; Carpentier AF
Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA.
Zhang Z; Tang LL; Zhan RY; Tong Y; Yao HP; Du LA
J Zhejiang Univ Sci; 2004 Oct; 5(10):1298-303. PubMed ID: 15362204
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma.
Chang CN; Huang YC; Yang DM; Kikuta K; Wei KJ; Kubota T; Yang WK
J Clin Neurosci; 2011 Aug; 18(8):1048-54. PubMed ID: 21715171
[TBL] [Abstract][Full Text] [Related]
13. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
[TBL] [Abstract][Full Text] [Related]
14. Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma.
Dillman RO; Duma CM; Ellis RA; Cornforth AN; Schiltz PM; Sharp SL; DePriest MC
J Immunother; 2009; 32(9):914-9. PubMed ID: 19816190
[TBL] [Abstract][Full Text] [Related]
15. Passive immunotherapeutic strategies for the treatment of malignant gliomas.
Nagasawa DT; Fong C; Yew A; Spasic M; Garcia HM; Kruse CA; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):481-95. PubMed ID: 22748660
[TBL] [Abstract][Full Text] [Related]
16. [Experimental studies on the antitumor activity of glioma-infiltrating lymphocytes against autologous glioma].
Li Y
Zhonghua Yi Xue Za Zhi; 1992 May; 72(5):284-6, 319. PubMed ID: 1327462
[TBL] [Abstract][Full Text] [Related]
17. Adoptive cell transfer therapy for malignant gliomas.
Ishikawa E; Takano S; Ohno T; Tsuboi K
Adv Exp Med Biol; 2012; 746():109-20. PubMed ID: 22639163
[TBL] [Abstract][Full Text] [Related]
18. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.
Kahlon KS; Brown C; Cooper LJ; Raubitschek A; Forman SJ; Jensen MC
Cancer Res; 2004 Dec; 64(24):9160-6. PubMed ID: 15604287
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with stimulated autologous lymphocytes in a case of a juvenile anaplastic glioma.
Thomas C; Schober R; Lenard HG; Lumenta CB; Jacques DB; Wechsler W
Neuropediatrics; 1992 Jun; 23(3):123-5. PubMed ID: 1641079
[TBL] [Abstract][Full Text] [Related]
20. T cell adoptive immunotherapy of newly diagnosed gliomas.
Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S
Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]